Correlation Between Enanta Pharmaceuticals and Evolus
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and Evolus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and Evolus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and Evolus Inc, you can compare the effects of market volatilities on Enanta Pharmaceuticals and Evolus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of Evolus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and Evolus.
Diversification Opportunities for Enanta Pharmaceuticals and Evolus
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enanta and Evolus is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and Evolus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolus Inc and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with Evolus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolus Inc has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and Evolus go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and Evolus
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to under-perform the Evolus. But the stock apears to be less risky and, when comparing its historical volatility, Enanta Pharmaceuticals is 1.79 times less risky than Evolus. The stock trades about -0.45 of its potential returns per unit of risk. The Evolus Inc is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest 1,675 in Evolus Inc on September 2, 2024 and sell it today you would lose (306.00) from holding Evolus Inc or give up 18.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enanta Pharmaceuticals vs. Evolus Inc
Performance |
| Timeline |
| Enanta Pharmaceuticals |
| Evolus Inc |
Enanta Pharmaceuticals and Evolus Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enanta Pharmaceuticals and Evolus
The main advantage of trading using opposite Enanta Pharmaceuticals and Evolus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, Evolus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will offset losses from the drop in Evolus' long position.| Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
| Evolus vs. Crinetics Pharmaceuticals | Evolus vs. Enanta Pharmaceuticals | Evolus vs. Amicus Therapeutics | Evolus vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |